Sitemap

More...

Miodrag Zec, Economist

We Live In A Dangerously Imbalanced World

From apparently simple questions, like the interest...

Françoise Jacob / UN Resident Coordinator In Serbia

Let’s Turn Green Together

Serbia, with eight million educated and connected...

H.E. Thomas Schieb, Ambassador Of Germany To Serbia

Continuity Is A German Trademark

There is no doubt that the Western...

Udo Eichlinger, President Of The German-Serbian Chamber Of Commerce

Cooperation Growing Wide And Deep

There are great opportunities for cooperation between...

News

Turkey To Declare 10 Ambassadors ‘Persona Non Grata’

The move means 10 ambassadors — including those of Germany and the United States — are now just one...

The Remote British Island That Remains Untouched By Covid

Alasdair and Gill Maclean say they felt a bit guilty having spent much of the past year happily living...

Western Balkans: Joint Statement of High Representative Josep Borrell and Secretary of State Antony Blinken

Following the recent meeting between EU High Representative Josep Borrell and U.S. Secretary of State Antony Blinken last week in...

Enlargement Package 2021 Adopted By The European Commission

Today, the European Commission adopted its 2021 Enlargement Package, providing a detailed assessment of the state of play and...

Serbia To Hold 5G Spectrum Auction In First Half Of 2022

AmCham and Ministry of Trade, Tourism and Telecommunications work together to tackle illicit trade online The 5G network and associated...

Ana Govedarica, Vice President Spokesperson of the Foreign Investors Council and Roche General Manager

Health Comes First

During COVID-19 and in the post-COVID-19 world, better healthcare systems are more important than ever. The main thing that the state has to deal with in the period ahead is digitalisation and data. Furthermore, when it comes to the pharma industry, it is of great importance for the state to define its needs and plans as soon as possible, to show how they expect our help and support

The issues of the economy and health have never before been connected so closely. With COVID-19 still lingering around and looming over us, we asked FIC Vice President Spokesperson and Roche General Manager Ana Govedarica about areas where the FIC could be of assistance to the Serbian Government in responding to the challenges of economic recovery as it relates to healthcare.

“Investments in healthcare cannot be decreased despite expected economic challenges, on the contrary, they must be greater than ever,” says our interlocutor.

“This pandemic has shown how important it is to have a resilient and efficient healthcare system, and how sensitive society is in the case that system doesn’t function right. It is well known that additional investments to secure more efficient treatment result in serious savings. Analysis of even medium-developed countries has demonstrated that it is justified to invest in a brand new therapy, despite the initial costs perhaps seeming high. Simply, every investment in an efficient healthcare system yields returns to society through multiple benefits, and also in other places both within and beyond the healthcare system.

A balance needs to be established between investing in infrastructure and new therapies as soon as possible, especially because innovative medicines – along with the development of new flexible & dynamic financing models based on treatment outcomes – will improve patients’ lives significantly. For example, if a healthcare fund only pays a producer for those medicines that resulted in an expected positive effect there is no risk to the payer. Moreover, investments should be directed towards the benefit for patients being the greatest.

How satisfied are you with the progress achieved in the activities of the FIC working group with the Government of Serbia? What motivated you to include the health minister in consultations?

– The FIC recognised the pharma industry as an important stakeholder in the healthcare system, and the Pharma Industry Committee was established as a result. The main aim of this sector-specific Committee is to promote necessary reforms to the health sector and health insurance, and to advocate for the full harmonisation of legislation with the EU and the removal of legislative obstacles. The main priorities, as defined in the Committee programme for 2018-2020, are: Allocation of additional financial resources for new drugs/indications reimbursements; Clear reimbursement criteria setting coupled with transparent decision-making process based upon them and completed within timelines determined by legislation; ALIMS to accelerate and simplify drug registration; Active participation in changes of the relevant laws and by-laws.

A positive trend is the introduction of Manage Entry Agreements between the NHIF and pharmaceutical companies, the quantification of funds required to place new medicines on the Reimbursement List, in the process of normatively resolving the issue of debts owed by some state institutions.

Ana Govedarica, General Manager, Roche Serbia

What is crucial for the coming period is steady funding for medicines, while expanding indications through a special-purpose transfer of budget funds to the NHIF and resolving the issue of settling old debts towards wholesalers.

Intense communication with the authorities in preparing the White Book is of great importance, because by exchanging information we reach realistic solutions based on facts.

By including the Minister of Health in this process, we have noticed the state’s greater understanding and greater efficiency for the difficulties that should be resolved.

After the health minister was included in the activities of the FIC working group with the Government, we noticed the state’s greater understanding for the difficulties that should be resolved

How will the experience gained by companies in organising work during the COVID-19 outbreak impact on the FIC’s action plans in the period ahead?

– Working in the conditions of pandemics has defined a new “normal”. In accordance with that, the FIC must adapt its plans to new needs and companies’ challenges, but also to develop some skills like working on virtual platforms, changes in communication, the organisation of business etc.

Which essential topics related to reforms should be addressed again in order to improve the resilience of the national economy against new challenges coming from the internal and external markets?

– During COVID-19 and in the post-COVID-19 world, better healthcare systems are more important than ever. The main thing that the state has to deal with in the period ahead is digitalisation and data. The whole future is centred around data, which will carry us to efficient healthcare.

When it comes to the pharma industry, it is of great importance for the state to define its needs and plans as soon as possible, to show how they expect our help and support… This is of additional importance if we consider that the majority of the pharmaceutical industry operates within large international companies, so it is important for local teams to set priorities for Serbia as soon as possible, and as clearly as possible.

Are you satisfied with the quality of the public dialogue linked to the crisis and what do you see as the FIC’s greatest contribution in this regard?

– COVID-19 has put the entire world in an unenviable situation. When you have to walk through fog, mistakes and poor assessments are possible. Therefore, public dialogue is of utmost importance, in order to create a better community for all of us.

The FIC can contribute by pointing out threats and opportunities, as well as by transferring experiences that companies have gained on other markets.

Considering the FIC’s experience in working with the government, what would you recommend to the new cabinet when it comes to cooperating with the business community?

– Intensive dialogue between the Government and business communities is of the utmost importance if we want to build a sound business climate and contribute to the growth of the entire society.

BENEFITS

Every investment in an efficient healthcare system yields returns to society through multiple benefits, and also in other places both within and beyond the health care system

DIALOGUE

Intensive dialogue between the Government and business communities is of the utmost importance if we want to build a sound business climate and contribute to the growth of the entire society

TRANSPARENCY

It is crucial to maintain and increase the transparency of the process of supplying medicines, as well as the stability of payments to suppliers

Related Articles

Ana Govedarica, FIC Vice President And Spokesperson (Roche Serbia General Manager)

FIC Experience & Knowhow At The Serbia’s Disposal

Serbia has good foundations for the digitalisation of health and could progress very quickly and provide high-quality services that meet the level of the...

Radomir Cerović, President Of The FIC Pharmaceutical Industry Committee (Roche d.o.o.)

Digitalisation Leads To Better Quality Healthcare Protection

The digitalisation of healthcare, which has been announced by the Government of Serbia, represents an important step towards the all-encompassing recovery of the state...

Nikola Selaković, Minister Of Foreign Affairs Of The Republic Of Serbia

With The Exception Of Kosovo, Our Values Align

This generation of politicians is obliged, first and foremost in the interests of Serbia, to attempt to once again find a common language and...

Foreign Investors Council First Cocktail After More Than A Year

Foreign Investors Club first cocktail after more than a year was held on 21 June. FIC Serbia member A1 Srbija d.o.o. sponsored the event and...

The Foreign Investors Council Held Its Regular Annual Assembly

The Foreign Investors Council held the regular annual session of the Assembly summarizing the key achievements and making solid basis for the future growth....

FIC Telco & Digital Economy Committee Created

Telecommunication & Digital Economy Committee was the last one to be established as part of the reorganization of FIC working committees in 2020. It...

Foreign Investors Council Presented The White Book 2020

The Foreign Investors Council presented the White Book 2020 to the highest Government officials and marked its 18th anniversery. Respecting epidemiological regulations, the presentation...